Back to Trades
Sell4
Jazz Pharmaceuticals plc
JAZZ
Total Value
$2.1M
Net $797.8K sold
Sales
$797.8K
2 transactions
Company Information
- Company Name
- Jazz Pharmaceuticals plc
- Ticker Symbol
- JAZZ
- CIK
- 0001232524
Insider Information
- Name
- Carr Patricia
- Role
- SVP, Chief Accounting Officer
- Location
- DUBLIN 4, L2
Officer
Filing Details
- Filing Date
- Dec 9, 2025
- Transaction Date
- Dec 5, 2025
- Accession Number
- 0001784606-25-000007
- Form Type
- 4
- Net Trading Amount
- -$797.8K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Dec 5, 2025 | Ordinary Shares | 160 | $171.11 | Sale | $27.4K |
| Dec 5, 2025 | Ordinary Shares | 4,500 | $140.67 | Exercise | $633.0K |
| Dec 5, 2025 | Ordinary Shares | 4,500 | $171.20 | Sale | $770.4K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Dec 5, 2025 | Derivative | 4,500 | $140.67 | Exercise | $633.0K |
Footnotes
- (F1)The Reporting Person acquired 160 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 28, 2025.
- (F2)Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $171.2001 to $171.2601. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- (F3)These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, March 1, 2018, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter. The option fully vested as of March 1, 2022.